Back
Onconetix 10K Form
Sell
19
ONCO
Onconetix
Last Price:
1.27
Seasonality Move:
-32.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONCO News And Ratings
See the #1 stock for the next 7 days that we like better than ONCO
ONCO Financial Statistics
Sales & Book Value
| Annual Sales: | $58.47K |
|---|---|
| Cash Flow: | $-3.22M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-64.14 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -108.80000 |
|---|---|
| Net Income (TTM): | $-53.12M |
| Gross Margin: | $-1.13M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Onconetix Earnings Forecast
Key Onconetix Financial Ratios
- The Gross Profit Margin over the past 2 years for ONCO is -1,927.77%.
- The Selling, General & Administrative Expenses for ONCO have been equal to 25,261.98% of Gross Profit Margin.
- The Research & Development expenses have been 3,334.03% of Revenue.
- The Interest Expense is -1.80% of Operating Income.
- The Net Earning history of ONCO is -63,981.00% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 0 years.
Onconetix Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONCO |
| Website: | onconetix.com |
Debt
| Debt-to-Equity Ratio: | -0.42 |
|---|---|
| Current Ratio: | 0.1 |
| Quick Ratio: | 0.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |